Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for cerebral blood flow after aneurysmal subarachnoid haemorrhage
2013-002457-30Phase 2Terminated
- Sponsor
- St George's, University of London
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of donepezil in subarachnoid hemorrhage (SAH) and cerebral vasospasm (2 arms), sponsored by St George's, University of London. Primary endpoint: Change in regional cerebral blood flow. Started Jul 2013; status: terminated.
02
Drugs
donepezil
03
Conditions
subarachnoid hemorrhage (SAH)cerebral vasospasm
Beyond the preview
Go deeper on 2013-002457-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002457-30.